DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Guarneri V, Frassoldati A, Bruzzi P. et al.
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Clin Breast Cancer 2008;
8 (05) 453-456
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.